Improvements in cholesterol efflux capacity of HDL and adiponectin contribute to mitigation in cardiovascular disease risk after bariatric surgery in a cohort with morbid obesity

Table 4 Correlation coefficients (r) for cholesterol efflux capacity with variables

Variable	Correlation of CEC with variables at baseline		Correlation of CEC with variables at 3 months		Correlation of percent change in CEC with percent change in variables
Variable	r	p-value	r	p-value	r	p-value
BMI (kg/m²)	− 0.09	0.50	− 0.04	0.79	0.12	0.50
HOMA2-IR	− 0.12	0.38	0.22	0.27	0.32	0.21
Apo A-I (mg/dl)	0.37	0.004	0.37	0.02	0.39	0.02
Apo B (mg/dl)	− 0.02	0.89	0.07	0.68	0.001	1.00
TC (mg/dl)	− 0.29	0.02	0.02	0.92	− 0.004	0.97
HDL-C (mg/dl)	0.17	0.19	− 0.06	0.73	0.08	0.65
LDL-C(mg/dl)	− 0.29	0.02	− 0.23	0.17	− 0.11	0.52
TG (mg/dl)	− 0.05	0.71	0.33	0.05	0.13	0.47
Adiponectin (µg/ml)	0.41	0.01	0.20	0.25	0.35	0.03
Log resistin	− 0.18	0.26	− 0.06	0.72	0.09	0.60
TNF alpha (pg/ml)	0.17	0.36	0.14	0.5	0.17	0.55
IL-10 (pg/ml)	− 0.08	0.62	0.26	0.13	− 0.14	0.43

BMI body mass index, HOMA2-IR homeostatic model assessment method-insulin resistance, Apo A-I apolipoprotein A-I, Apo B apolipoprotein B, HDL-C high density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol, TG triglycerides, CEC cholesterol efflux capacity, IL-10 interleukin 10, TNF-alpha Tumor necrosis factor-alpha. r represents Pearson correlation coefficient. Bold emphasis denotes a significant p-value i.e. < 0.05

ISSN: 1758-5996